Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1β), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls

Infection and Immunity

Volumn 72, Issue 10, 2004, Pages 5630-5637

  Lyke, K E ^a   Burges, R ^a   Cissoko, Y ^b   Sangare, L ^b   Dao, M ^b   Diarra, I ^b   Kone, A ^b   Harley, R ^a   Plowe, C V ^a   Doumbo, O K ^b   Sztein, M B ^a,c  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b UNIVERSITY OF BAMAKO   (Mali)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; AGE; ANEMIA; ARTICLE; BRAIN MALARIA; CASE CONTROL STUDY; CHILD; COMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNE RESPONSE; INFANT; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MALI; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEIZURE; SERUM; TROPHOZOITE;

ADOLESCENT; AGING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HEALTH; HUMANS; INFANT; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; MALARIA, FALCIPARUM; MALE; MALI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644337572     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.10.5630-5637.2004     Document Type: Article

References (51)

1. Abrams, E. T., H. Brown, S. W. Chensue, G. D. Turner, E. Tadesse, V. M. Lema, M. E. Molyneux, R. Rochford, S. R. Meshnick, and S. J. Rogerson. 2003. Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. J. Immunol. 170:2759-2764.
2. Brown, H., G. Turner, S. Rogerson, M. Tembo, J. Mwenechanya, M. Molyneux, and T. Taylor. 1999. Cytokine expression in the brain in human cerebral malaria. J. Infect. Dis. 180:1742-1746.
3. Cai, G., R. A. Kastelein, and C. A. Hunter. 1999. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18. Eur. J. Immunol. 29:2658-2665.
4. Clark, I. A., and G. Chaudhri. 1988. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br. J. Hematol. 70:99-103.
5. Clark, I. A., W. B. Cowden, G. A. Butcher, and N. H. Hunt. 1987. Possible roles of tumor necrosis factor in the pathology of malaria. Am. J. Pathol. 129:192-199.
6. Clark, I. A., N. H. Hunt, G. A. Butcher, and W. B. Cowden. 1987. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J. Immunol. 139:3493-3496.
7. Conti, P., D. Kempuraj, K. Kandere, M. Di Gioacchino, R. C. Barbacane, M. L. Castellani, M. Felaco, W. Boucher, R. Letourneau, and T. C. Theoharides. 2003. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol. Lett. 86:123-129.
8. Day, N. P., T. T. Hien, T. Schollaardt, P. P. Loc, L. V. Chuong, T. T. Chau, N. T. Mai, N. H. Phu, D. X. Sinh, N. J. White, and M. Ho. 1999. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria. J. Infect. Dis. 180:1288-1297.
9. de Waal, M. R., J. Haanen, H. Spits, M. G. Roncarolo, V. A. Te, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-01 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
10. +-cell-mediated pathology. Proc. Natl. Acad. Sci. USA 91:8097-8101.
11. Ferreira, A., L. Schofield, V. Enea, H. Schellekens, M. P. van der, W. E. Collins, R. S. Nussenzweig, and V. Nussenzweig. 1986. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 232:881-884.
12. Finley, R. W., L. J. Mackey, and P. H. Lambert. 1982. Virulent Plasmodium berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice. J. Immunol. 129:2213-2218.
13. Friedland, J. S., M. Ho, D. G. Remick, D. Bunnag, N. J. White, and G. E. Griffin. 1993. Interleukin-8 and Plasmodium falciparum malaria in Thailand. Trans. R. Soc. Trop. Med. Hyg. 87:54-55.
14. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
15. Graham, S. M., C. A. Hart, E. M. Molyneux, A. L. Walsh, and M. E. Molyneux. 2000. Malaria and Salmonella infections: cause or coincidence? Trans. R. Soc. Trop. Med. Hyg. 94:227.
16. Graham, S. M., A. L. Walsh, E. M. Molyneux, A. J. Phiri, and M. E. Molyneux. 2000. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans. R. Soc. Trop. Med. Hyg. 94:310-314.
17. Grau, G. E., H. Heremans, P. F. Piguet, P. Pointaire, P. H. Lambert, A. Billiau, and P. Vassalli. 1989. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated over-production of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 86:5572-5574.
18. Grau, G. E., P. F. Piguet, P. Vassalli, and P. H. Lambert. 1989. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112:49-70.
19. Grau, G. E., T. E. Taylor, M. E. Molyneux, J. J. Wirima, P. Vassalli, M. Hommel, and P. H. Lambert. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1586-1591.
20. Harpaz, R., R. Edelman, S. S. Wasserman, M. M. Levine, J. R. Davis, and M. B. Sztein. 1992. Serum cytokine profiles in experimental human malaria: relationship to protection and disease course after challenge. J. Clin. Investig. 90:515-523.
21. Ho, M., M. M. Sexton, P. Tongtawe, S. Looareesuwan, P. Suntharasamai, and H. K. Webster. 1995. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J. Infect. Dis. 172:838-844.
22. Ho, M., and N. J. White. 1999. Molecular mechanisms of cytoadherence in malaria. Am. J. Physiol. 276:C1231-C1242.
23. Hoffman, S. L., J. M. Crutcher, S. K. Puri, A. A. Ansari, F. Villinger, E. D. Franke, P. P. Singh, F. Finkelman, M. K. Gately, G. P. Dutta, and M. Sedegah. 1997. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat. Med. 3:80-83.
24. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205-1208.
25. Jahiel, R. I., J. Vilcek, and R. S. Nussenzweig. 1970. Exogenous interferon protects mice against Plasmodium berghei malaria. Nature 227:1350-1351.
26. Kern, P., C. J. Hemmer, J. Van Damme, H. J. Gruss, and M. Dietrich. 1989. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87:139-143.
27. Kurtzhals, J. A., V. Adabayeri, B. Q. Goka, B. D. Akanmori, J. O. Oliver-Commey, F. K. Nkrumah, C. Behr, and L. Hviid. 1998. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351:1768-1772.
28. Kwiatkowski, D., A. V. Hill, I. Sambou, P. Twumasi, J. Castracane, K. R. Manogue, A. Cerami, D. R. Brewster, and B. M. Greenwood. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204.
29. Kwiatkowski, D., M. E. Molyneux, S. Stephens, N. Curtis, N. Klein, P. Pointaire, M. Smit, R. Allan, D. R. Brewster, G. E. Grau, et al. 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med. 86:91-98.
30. Kwiatkowski, D., and M. Nowak. 1991. Periodic and chaotic host-parasite interactions in human malaria. Proc. Natl. Acad. Sci. USA 88:5111-5113.
31. Malaguarnera, L., and S. Musumeci. 2002. The immune response to Plasmodium falciparum malaria. Lancet Infect. Dis. 2:472-478.
32. Malaguarnera, L., S. Pignatelli, J. Simpore, M. Malaguarnera, and S. Musumeci. 2002. Plasma levels of interleukin-12 (IL-12), interleukin-18 (IL-18) and transforming growth factor beta (TGF-β) in Plasmodium falciparum malaria. Eur. Cytokine Netw. 13:425-430.
33. May, J., B. Lell, A. J. Luty, C. G. Meyer, and P. G. Kremsner. 2000. Plasma interleukin-10:tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J. Infect. Dis. 182:1570-1573.
34. Mshana, R. N., J. Boulandi, N. M. Mshana, J. Mayombo, and G. Mendome. 1991. Cytokines in the pathogenesis of malaria: levels of IL-1β, IL-4, IL-6, TNF-α, and IFN-γ in plasma of healthy individuals and malaria patients in a holoendemic area. J. Clin. Lab. Immunol. 34:131-139.
35. Newsome, F. 1984. Increased phagocytosis of non-parasitized red cells in Plasmodium berghei malaria. Ann. Trop. Med. Parasitol. 78:323-325.
36. O'Garra, A., and N. Arai. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10:542-550.
37. Othoro, C., A. A. Lal, B. Nahlen, D. Koech, A. S. Orago, and V. Udhayakumar. 1999. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J. Infect. Dis. 179:279-282.
38. Perkins, D. J., J. B. Weinberg, and P. G. Kremsner. 2000. Reduced interleukin-12 and transforming growth factor-β1 in severe childhood malaria: relationship of cytokine balance with disease severity. J. Infect. Dis. 182:988-992.
39. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22:929-979.
40. Peyron, F., N. Burdin, P. Ringwald, J. P. Vuillez, F. Rousset, and J. Banchereau. 1994. High levels of circulating IL-10 in human malaria. Clin. Exp. Immunol. 95:300-303.
41. Porta, J., A. Carota, G. P. Pizzolato, E. Wildi, M. C. Widmer, C. Margairaz, and G. E. Grau. 1993. Immunopathological changes in human cerebral malaria. Clin. Neuropathol. 12:142-146.
42. Sarthou, J. L., G. Angel, G. Aribot, C. Rogier, A. Dieye, B. A. Toure, B. Diatta, P. Seignot, and C. Roussilhon. 1997. Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria. Infect. Immun. 65:3271-3276.
43. Schofield, L., A. Ferreira, R. Altszuler, V. Nussenzweig, and R. S. Nussenzweig. 1987. Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J. Immunol. 139:2020-2025.
44. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700-10702.
45. Shaffer, N., G. E. Grau, K. Hedberg, F. Davachi, B. Lyamba, A. W. Hightower, J. G. Breman, and N. D. Phuc. 1991. Tumor necrosis factor and severe malaria. J. Infect. Dis. 163:96-101.
46. Taverne, J., N. Sheikh, J. B. De Souza, J. H. Playfair, L. Probert, and G. Kollias. 1994. Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology 82:397-403.
47. Udomsangpetch, R., S. Chivapat, P. Viriyavejakul, M. Riganti, P. Wilairatana, E. Pongponratn, and S. Looareesuwan. 1997. Involvement of cytokines in the histopathology of cerebral malaria. Am. J. Trop. Med. Hyg. 57:501-506.
48. Urquhart, A. D. 1994. Putative pathophysiological interactions of cytokines and phagocytic cells in severe human falciparum malaria. Clin. Infect. Dis. 19:117-131.
49. Van Vlasselaer, P., N. Falla, H. R. Van Den, J. Dasch, and M. R. de Waal. 1995. Interleukin-10 stimulates hematopoiesis in murine osteogenic stroma. Clin. Orthop. 313:103-114.
50. Wenisch, C., K. F. Linnau, S. Looareesuwan, and H. Rumpold. 1999. Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria. J. Infect. Dis. 179:747-750.
51. World Health Organization. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1):S1-S90.